Exporting Horses to French Polynesia

30 June 2008

horaniec.fpl

You are viewing animal export requirements. They outline overseas country requirements for live animal and animal germplasm (semen and embryos) exported from New Zealand.

The document is also available as a PDF: horaniec.fpl (24 KB)
Information on viewing PDF files

Overseas Market Access Requirements Notification - Animal Products Act 1999 - MAF Biosecurity New Zealand

Ref: AE-PF 13L

1. Statutory authority

Pursuant to section 60 of the Animal Products Act 1999:

(i) I notify the following overseas market access requirements, entitled horses to French Polynesia

(ii) Revoke OMAR B HORANIEC.FPL 06.03.01.

This notice takes effect from date of signing.

Dated at Wellington this 23rd day of July 2008.

Signed: Tim Knox
Director
Border Standards
MAF Biosecurity New Zealand
(pursuant to delegated authority)

2. French Polynesian Requirements

Horses to French Polynesia must comply with the import requirements of French Polynesia listed in this notice as follows:

2.1 An import permit is required for the exportation of horses from New Zealand to French Polynesia.

2.2 An official veterinarian authorised by the New Zealand Ministry of Agriculture and Forestry, must certify, after due enquiry, the following:

2.2.1 New Zealand is officially free from vesicular stomatitis, African horse sickness, Japanese encephalitis, rabies, dourine, glanders, anthrax, contagious equine metritis, equine epizootic lymphangitis, equine influenza (virus type A), equine piroplasmosis, horse pox, Nipah virus, Hendra virus, equine encephalomyelitis (VEE, EEE, WEE), West Nile fever, and screwworm (Cochliomya hominivorax).

2.2.2 The horses for export to French Polynesia originate from premises in which no cases of the following diseases have been recorded:

2.2.2.1 leptospirosis, equine rhinopneumonitis, and horse mange during the 3 months preceding their departure.

2.2.3 The horses have not been present on any premises declared to be a Restricted Place (Biosecurity Act 1993, section 130) for equine infectious anaemia, nor had contact with horses from such premises.

2.2.4 Horses for export are not known to be or suspected to be currently infected with equine arteritis virus, and have had no contact during the 3 months prior to export with any of the known sero-positive carrier stallions in New Zealand.

2.2.5 The horses for export have not been vaccinated against equine viral arteritis, equine encephalomyelitis, and African horse sickness.

2.2.6 The horses for export were isolated for a period of 1 month during which they had no contact with other animals of a lesser health or isolation status.

2.2.7 During this period of isolation, the horses for export were subjected to tests for the following diseases, with negative results:

2.2.7.1 equine viral arteritis, using a serum neutralisation test (negative is a reaction at a dilution of equal or less than 1:4)

2.2.7.2 equine infectious anaemia, using an agar gel immunodiffusion (AGID) test.

2.2.8 During the period of isolation, the horses were submitted to the following treatments:

2.2.8.1 two injections of dihydrostreptomycin (25mg/kg of live weight) at an interval of approximately 14 days. Date of injections 1 and 2 to be recorded on the export certificate

2.2.8.2 against external parasites (ticks) within 7 days of departure and internal parasites using products registered in New Zealand for use in horses. Name of products, active ingredients used and date of treatments to be recorded on the export certificate.

2.2.9 The animals for export were examined within 48 hours of the scheduled time of export and found to be free from clinical signs of contagious, infectious or parasitic diseases, and are in a fit condition to travel.

3. Definitions

For the purposes of this document:

Any term or expression that is defined in the Animal Products Act 1999 and used, but not defined in this document, has the same meaning as in this Act.

Explanatory note

This OMAR is based on the export certificate for horses to French Polynesia dated 30 June 2008.

Additional information on OMAR notification – HORANIEC.FPL 30.06.08

1. This OMAR replaces the previous one dated 6 March 2001. The changes made were mainly editorial, with the addition of equine encephalomyelitis and African horse sickness in clause 2.2.5.

2. An import permit is required and can be obtained from:

Ministere de l’Agriculture et de l’Elevage
Service du Développement Rural
BP 100 Papeete - TAHITI 2444-001
Telephone: 00 689 42 81 44
Facsimile: 00 689 42 08 31
E-mail:sdevrural@mail.pf

3. Official Veterinarian means a civil veterinarian or a specially appointed veterinarian, as authorised by the New Zealand Ministry of Agriculture and Forestry.

4. In relation to clause 2.2.3 for EIA, horses for export must not have been present on a Restricted Place from the 24 May 1999 until revocation of the Restricted Place notice, nor had contact with horses from such premises.

Section 61.A of the Animal Products Amendments Act 2005 states that 'The Crown is not liable, and nor is the Director-General or any employee of the Ministry liable, for any loss arising through the refusal or failure of the relevant authority of an overseas market to admit export animal material or animal product to that market'.